Research Article
Serum Superoxide Dismutase Is Associated with Vascular Structure and Function in Hypertensive and Diabetic Patients
Table 2
Pearson correlations between serum superoxide dismutase and parameters of vascular structure and function and cardiovascular risk.
| | Superoxide dismutase | | All patients | DIA + HYP | DIA | HYP | Control |
| Intima-media thickness medium average | −0.08 | 0.06 | 0.45 | −0.12 | −0.22 | Intima-media thickness maximum average | −0.06 | 0.06 | 0.41 | −0.07 | −0.22 | Pulse wave velocity | −0.15 | −0.06 | −0.03 | −0.16 | 0.25 | Peripheral augmentation index | −0.16 | −0.08 | −0.09 | −0.13 | −0.37 | Central augmentation index | −0.16 | −0.01 | −0.18 | −0.10 | −0.35 | AASI | −0.19 | −0.32 | 0.20 | −0.24 | −0.15 | Pulse pressure | −0.17 | −0.20 | −0.07 | −0.18 | −0.19 | D’Agostino cardiovascular risk | −0.03 | −0.09 | 0.46 | −0.06 | −0.10 | 8-Hydroxy-2-deoxyguanosine | −0.17 | −0.29 | 0.21 | −0.21 | −0.22 | Uric acid | 0.19 | 0.19 | 0.25 | 0.20 | 0.28 | HDL | −0.18 | −0.10 | −0.22 | −0.18 | −0.28 | LDL | 0.02 | −0.06 | 0.40 | 0.13 | −0.10 | Triglycerides | 0.19 | 0.19 | 0.44 | 0.20 | 0.25 |
|
|
AASI: ambulatory arterial stiffness index; DIA: diabetic nonhypertensive patients; DIA + HYP: diabetic hypertensive patients; HDL: cholesterol associated with high density lipoproteins; HYP: hypertensive patients; LDL: cholesterol associated with low density lipoproteins. Statistical significant differences: ; .
|